NR1I2 and colorectal carcinoma: Its role in the latter function was also demonstrated in a study by, in which it was reported that PXR could be utilized as a biomarker for the prediction of resistance to platinum agents or oxaliplatin (L-OHP) transport capacity (L-OHP) in CRC [13].